Aripiprazole

CAS 129722-12-9 43 current records 6 historicalSmall Molecule

Who holds supplier records for Aripiprazole? 43 organisations hold a current record for Aripiprazole: an active US FDA Type II Drug Master File or a CEP. A further 6 organisations have only historical (inactive) DMF filings. 23 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (23), China (5), Italy (2), Netherlands (2) and 6 other countries (6); not recorded for 5.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Aripiprazole: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/aripiprazole

Reading the evidence

  • 43 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    23 of the 38 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 25 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Aripiprazole expires 15 Dec 2041. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (43)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Aripiprazole. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Aripiprazole sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (23)

Certificates of Suitability on the EDQM register for Aripiprazole, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 34 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
MSN PHARMACHEM PRIVATE LIMITED SangareddyIN
CEP 2014-285 - Rev 02
Aripiprazole, Type-1, Micronised and Non-micronised
Oct 2026—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2020-311 - Rev 03
Aripiprazole, Process IV
Oct 2026—
BAL PHARMA LIMITED BengaluruIN
CEP 2023-383 - Rev 01
Aripiprazole
Oct 2026—
SYNTHON B.V. NijmegenNL
CEP 2019-191 - Rev 03
Aripiprazole, Micronised
Oct 2026Inspected May 2024
Netherlands
MACLEODS PHARMACEUTICALS LIMITED MumbaiIN
CEP 2021-282 - Rev 01
Aripiprazole, 1280
Aug 2026—
UNICHEM LABORATORIES LIMITED MumbaiIN
CEP 2015-010 - Rev 03
Aripiprazole
Jul 2026—
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2014-011 - Rev 02
Aripiprazole, Form-B, micronised and non-micronised
Jun 2026Inspected May 2026
Italy
ALKEM LABORATORIES LIMITED MumbaiIN
CEP 2024-180 - Rev 00
Aripiprazole
Jan 2026—
NEULAND LABORATORIES LIMITED HyderabadIN
CEP 2017-289 - Rev 04
Aripiprazole, Form B
Jan 2026—
OLON S.P.A. RodanoIT
CEP 2014-188 - Rev 02
Aripiprazole
Dec 2025Inspected Mar 2025
Italy
JUBILANT BIOSYS LIMITED NanjangudIN
CEP 2013-324 - Rev 02
Aripiprazole
Nov 2025—
MATRIX PHARMACORP PRIVATE LIMITED Sangareddy DistrictIN
CEP 2013-330 - Rev 03
Aripiprazole
Sept 2025—
NIFTY LABS PRIVATE LIMITED HyderabadIN
CEP 2017-198 - Rev 04
Aripiprazole
Sept 2025—
ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. Starogard GdańskiPL
CEP 2013-230 - Rev 03
Aripiprazole
Sept 2025Inspected Jul 2026
Poland
TAPI NL B.V. AmsterdamNL
CEP 2018-267 - Rev 03
Aripiprazole, Form II
Jun 2025—
HETERO LABS LIMITED HyderabadIN
CEP 2013-361 - Rev 02
Aripiprazole, Type-I
May 2025—
CADILA PHARMACEUTICALS LIMITED AnkleshwarIN
CEP 2016-308 - Rev 02
Aripiprazole, Form 1
Dec 2024—
ALEMBIC PHARMACEUTICALS LIMITED VadodaraIN
CEP 2013-292 - Rev 02
Aripiprazole
Aug 2024—
SMS PHARMACEUTICALS LIMITED HyderabadIN
CEP 2022-435 - Rev 00
Aripiprazole
Aug 2024—
COHANCE LIFESCIENCES LIMITED MumbaiIN
CEP 2016-021 - Rev 02
Aripiprazole
Jul 2024—
RUYUAN HEC PHARM CO., LTD. ShaoguanCN
R1-CEP 2016-208 - Rev 00
Aripiprazole
Jun 2023—
EGIS Pharmaceuticals PLC BudapestHU
R1-CEP 2014-252 - Rev 02
Aripiprazole
Jul 2022—
ZYDUS LIFESCIENCES LIMITED VadodaraIN
R0-CEP 2019-002 - Rev 01
Aripiprazole
Jul 2022—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (6)

Organisations whose Type II DMFs for Aripiprazole are no longer active. These show a past filing, not current supply.

Show all 6 historical records

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (115 listed products contain Aripiprazole). The latest listed patent expires 15 Dec 2041. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Aripiprazole is an atypical antipsychotic medication used primarily in the treatment of schizophrenia and bipolar disorder. It is notable for its unique mechanism of action that involves partial agonist activity at D2 dopamine and 5-HT1A serotonin receptors.

Chemical identity

IUPAC name
7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one
Canonical SMILES
C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl
InChIKey
CEUORZQYGODEFX-UHFFFAOYSA-N
Synonyms
Abilify API, abilify, abilify maintena, abilify mycite, abilify mycite kit, aripiprex, mezofy, nsc-759266, opc-14597, opc-31

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Atypical Antipsychotic

Therapeutic areas

PsychiatryNeurology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Aripiprazole?

43 organisations hold an active US FDA Type II Drug Master File or a CEP for Aripiprazole: Alembic Pharmaceuticals Limited (India), APITORIA PHARMA PRIVATE LTD (India), Hetero Labs Limited (India), MATRIX PHARMACORP PRIVATE LTD (India), MSN PHARMACHEM PRIVATE LTD (India), Neuland Laboratories Limited (India), Zakłady Farmaceutyczne Polpharma S.A. (Poland) and INTERQUIM SA (Peru), and 35 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Aripiprazole Drug Master Files are active?

Alembic Pharmaceuticals Limited (DMF 23300, 43624), APITORIA PHARMA PRIVATE LTD (DMF 33827, 24997), Hetero Labs Limited (DMF 22563, 31455), MATRIX PHARMACORP PRIVATE LTD (DMF 31257, 19554), MSN PHARMACHEM PRIVATE LTD (DMF 24090, 29135), Neuland Laboratories Limited (DMF 22889, 36451), Zakłady Farmaceutyczne Polpharma S.A. (DMF 23314, 33204) and INTERQUIM SA (DMF 37184, 34969) and 31 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Aripiprazole records mean?

6 organisations have only inactive Type II DMFs for Aripiprazole. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Aripiprazole have a European Certificate of Suitability?

Yes. 23 organisations hold a valid CEP for Aripiprazole on the EDQM register, including MSN PHARMACHEM PRIVATE LIMITED Sangareddy (IN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN), BAL PHARMA LIMITED Bengaluru (IN), SYNTHON B.V. Nijmegen (NL), MACLEODS PHARMACEUTICALS LIMITED Mumbai (IN) and UNICHEM LABORATORIES LIMITED Mumbai (IN) and 17 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Aripiprazole?

Yes. The latest patent listed for an approved US product containing Aripiprazole expires 15 Dec 2041, across 115 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Aripiprazole supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Aripiprazole?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.